Flortanidazole F18

N/A

Report date: 2025/12/01 17:17:02
NME

Base Information

Drug NameFlortanidazole F18
Drug Alias Name18F-flortanidazoleflortanidazole (18F)[18F]-HX4
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesSiemens
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSiemens Molecular Imaging Inc
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsLung NeoplasmsHead and Neck Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A